Next-Generation Antibody Market Key Players and Forecast by 2028

Next-Generation Antibody Market Forecast to 2028 - Analysis By Therapeutic Area (Oncology and Autoimmune or Inflammatory) and Technology (Antibody-Drug Conjugates, Bispecific Antibodies, Fc Engineered Antibodies, Antibody Fragments and Antibody-Like Proteins, and Biosimilar Antibody Products)

Status : Published
Report Code : TIPRE00006412

Category : Life Sciences
No. of Pages : 181

Available Report Formats :

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Therapeutic Area, and Technology

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

What is the market CAGR value of the next-generation antibody market during the forecast period?

The global next-generation antibody market is expected to reach US$ 5,428.41 million in 2028 from US$ 12,050.13 million in 2021. The market is estimated to grow with a CAGR of 11.9% from 2021-2028.

Which is the therapeutic area where the next-generation antibodies are often used?

The next-generation antibodies are used in the therapeutic areas- oncology and oncology, and autoimmune or inflammatory. Mostly, the next-generation antibodies are used in the oncology field. The oncology segment is likely to hold the largest share of the market in 2021. Moreover, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period, due to the vast usage of next-generation antibodies for cancers, high volume consumption, and product innovation for this field

Who are the key players in the next-generation antibody market?

The disposable pipettes tips market majorly consists of players like F. HOFFMANN-LA ROCHE LTD., Kyowa Kirin Co., Ltd., Seagen Inc., ImmunoGen, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Pfizer Inc., Catalent Inc, AstraZeneca, and Xencor among others.

What are the drivers and restraints for the next-generation antibody market?

The growth of the market is attributed to the increasing prevalence of cancer and growing demand for next-generation antibody therapeutics drives the market growth. However, the complications associated with the manufacturing and approvals hampers the market growth.

Which is the potential market for next-generation antibodies in terms of the region?

The Asia Pacific registered as the fastest-growing region in the global next-generation antibody market. The market in this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, expanding R&D, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the next-generation antibody market players to grow during the forecast period.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Next-generation Antibody Market – By Therapeutic Area

1.3.2 Global Next-generation Antibody Market – By Technology

1.3.3 Global Next-generation Antibody Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Next-generation Antibody Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Next-generation Antibody Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cancer

5.1.2 Growing Demand for Next-Generation Antibody Therapeutics

5.2 Market Restraints

5.2.1 Complications Associated with Manufacturing and Approvals

5.3 Market Opportunities

5.3.1 Proliferation of Biotechnology Industry in Developing Regions

5.4 Future Trends

5.4.1 Developments in Next-Generation Antibodies

5.5 Impact Analysis

6. Next-generation Antibody Market– Global Analysis

6.1 Global Next-generation Antibody Market Revenue Forecast and Analysis

6.2 Global Next-generation Antibody Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Next-generation Antibody Market Revenue and Forecasts To 2028– by Therapeutic Area

7.1 Overview

7.2 Global Next-generation Antibody Market, By Therapeutic Area, 2021 & 2028 (%)

7.3 Oncology

7.3.1 Overview

7.3.2 Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Autoimmune or Inflammatory

7.4.1 Overview

7.4.2 Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

8. Next-generation Antibody Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Global Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

8.3 Antibody-drug conjugates

8.3.1 Overview

8.3.2 Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.4 Bispecific antibodies

8.4.1 Overview

8.4.2 Bispecific antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.5 Fc engineered antibodies

8.5.1 Overview

8.5.2 Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.6 Antibody fragments and antibody-like proteins

8.6.1 Overview

8.6.2 Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biosimilar antibody products

8.7.1 Overview

8.7.2 Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

9. Next-generation Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis

9.1 North America: Next-generation Antibody Market

9.1.1 Overview

9.1.2 North America: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3 North America: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (US$ Million)

9.1.4 North America: Next-generation Antibody Market, by Technology, 2019–2028 (US$ Million)

9.1.5 North America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.1 Overview

9.1.5.1.2 US: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.1.3 US: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (US$ Million)

9.1.5.1.4 US: Next-generation Antibody Market, by Technology, 2019–2028 (US$ Million)

9.1.5.2 Canada: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.1 Overview

9.1.5.2.2 Canada: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.2.3 Canada: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (US$ Million)

9.1.5.2.4 Canada: Next-generation Antibody Market, by Technology, 2019–2028 (US$ Million)

9.1.5.3 Mexico: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.1 Overview

9.1.5.3.2 Mexico: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.1.5.3.3 Mexico: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (US$ Million)

9.1.5.3.4 Mexico: Next-generation Antibody Market, by Technology, 2019–2028 (US$ Million)

9.2 Europe: Next-generation Antibody Market

9.2.1 Overview

9.2.2 Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.3 Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.4 Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5 Europe: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

9.2.5.1 Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.1 Overview

9.2.5.1.2 Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.3 Germany: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.1.4 Germany: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5.2 France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.1 Overview

9.2.5.2.2 France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.3 France: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.2.4 France: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5.3 UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.1 Overview

9.2.5.3.2 UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.3 UK: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.3.4 UK: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5.4 Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.1 Overview

9.2.5.4.2 Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.3 Italy: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.4.4 Italy: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5.5 Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.1 Overview

9.2.5.5.2 Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.3 Spain: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.5.4 Spain: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.2.5.6 Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.1 Overview

9.2.5.6.2 Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.3 Rest of Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

9.2.5.6.4 Rest of Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

9.3 Asia Pacific Next-generation Antibody Market Revenue and Forecasts To 2028

9.3.1 Overview

9.3.2 Asia Pacific Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.3 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.4 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.3.5 Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

9.3.5.1 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.1.1 Overview

9.3.5.1.2 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.1.3 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.1.4 Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.3.5.2 China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.2.1 Overview

9.3.5.2.2 China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.2.3 China: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.2.4 China: Next-generation Antibody Market Revenue and Forecasts to 2028, by Technology (US$ Million)

9.3.5.3 India Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.3.1 Overview

9.3.5.3.2 India: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.3.3 India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.3.4 India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.3.5.4 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.4.1 Overview

9.3.5.4.2 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.4.3 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.4.4 South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.3.5.5 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.5.1 Overview

9.3.5.5.2 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.3.5.5.3 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.5.4 Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Application (US$ Million)

9.3.5.6 Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.1 Overview

9.3.5.6.2 Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.3.5.6.3 Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.3.5.6.4 Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.4 Middle East & Africa Next-generation Antibody Market Revenue and Forecasts To 2028

9.4.1 Overview

9.4.2 Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.3 Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.4.4 Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.4.5 Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

9.4.5.1 UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.1.1 Overview

9.4.5.1.2 UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.1.3 UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.4.5.1.4 UAE: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.4.5.2 Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.2.1 Overview

9.4.5.2.2 Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.2.3 Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.4.5.2.4 Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.4.5.3 South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.3.1 Overview

9.4.5.3.2 South Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.3.3 South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.4.5.3.4 South Africa: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.4.5.4 Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.4.1 Overview

9.4.5.4.2 Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5.4.3 Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.4.5.4.4 Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.5 South and Central America Next-generation Antibody Market Revenue and Forecasts To 2028

9.5.1 Overview

9.5.2 South and Central America: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.3 South and Central America: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5.4 South and Central America: Next-generation Antibody Market, by Technology, 2019–2028 (USD Million)

9.5.5 South and Central America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

9.5.5.1 Brazil: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.1.1 Overview

9.5.5.1.2 Brazil: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.1.3 Brazil: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5.5.1.4 Brazil: Next-generation Antibody Market, by Technology, 2019–2028 (USD Million)

9.5.5.2 Argentina: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.2.1 Overview

9.5.5.2.2 Argentina: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.2.3 Argentina: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5.5.2.4 Argentina: Next-generation Antibody Market, by Technology, 2019–2028 (USD Million)

9.5.5.3 Rest of South & Central America: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.3.1 Overview

9.5.5.3.2 Rest of South & Central America: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.3.3 Rest of South & Central America: Next-generation Antibody Market, by Therapeutic Area, 2019–2028 (USD Million)

9.5.5.3.4 Rest of South & Central America: Next-generation Antibody Market, by Technology, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Next-generation Antibody Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Next-generation Antibody Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Next-generation Antibody Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 F. HOFFMANN-LA ROCHE LTD.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Kyowa Kirin Co., Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Seagen Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ImmunoGen, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Takeda Pharmaceutical Company Limited

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Amgen Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Pfizer Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Catalent Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 AstraZeneca

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Xencor

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. New Cancer Cases Registered Worldwide, 2020

Table 2. North America Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 4. US Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 9. Mexico Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 10. Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 11. Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 12. Germany: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 13. Germany: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 15. France: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 18. Italy: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 19. Italy: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 20. Spain: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 21. Spain: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 22. Rest of Europe: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (US$ Million)

Table 23. Rest of Europe: Next-generation Antibody Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million).

Table 25. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 26. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 27. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 28. China: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 29. China: Next-generation Antibody Market Revenue and Forecasts to 2028, by Technology (US$ Million)

Table 30. India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 31. India: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 32. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 33. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 34. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 35. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 36. Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 37. Rest of Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 38. Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million).

Table 39. Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 40. UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 41. UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 42. Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 43. Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 44. South Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 45. South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 46. Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 47. Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 48. South and Central America: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 49. South and Central America: Next-generation Antibody Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 50. Brazil: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 51. Brazil: Next-generation Antibody Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 52. Argentina: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 53. Argentina: Next-generation Antibody Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 54. Rest of South & Central America: Next-generation Antibody Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 55. Rest of South & Central America: Next-generation Antibody Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 56. Organic Developments in the Next-generation Antibody Market

Table 57. Inorganic Developments in the Next-generation Antibody Market

Table 58. Glossary of Terms

LIST OF FIGURES

Figure 1. Next-generation Antibody Market Segmentation

Figure 2. Next-generation Antibody Market, By Region

Figure 3. Global Next-generation Antibody Market Overview

Figure 4. Oncology Segment Held Largest Share of Therapeutic Area Segment in Next-generation Antibody Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Next-generation Antibody Market, by Geography (US$ Million)

Figure 7. Global Next-generation Antibody Market- Leading Country Markets (US$ Million)

Figure 8. Global Next-generation Antibody Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Next-Generation Antibody Market Impact Analysis of Driver and Restraints

Figure 16. Global Next-generation Antibody Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Next-generation Antibody Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Next-generation Antibody Market

Figure 19. Global Next-generation Antibody Market, by Therapeutic Area, 2021 & 2028 (%)

Figure 20. Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Global Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

Figure 23. Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Bispecific antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27. Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. North America: Next-generation Antibody Market, by Key Country – Revenue (2021) (US$ Million)

Figure 29. North America Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

Figure 31. US: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Canada: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Mexico: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Europe: Next-generation Antibody Market, by Key Country – Revenue (2021) (US$ Million)

Figure 35. Europe: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

Figure 36. Europe: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

Figure 37. Germany: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. France: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. UK: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Italy: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Spain: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42. Rest of Europe: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. Asia Pacific Next-generation Antibody Market Overview, by Country (2021)

Figure 44. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45. Asia Pacific: Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

Figure 46. Japan: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47. China: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 48. India: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49. South Korea: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50. Australia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 51. Rest of Asia Pacific: Next-generation Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. Middle East & Africa Next-generation Antibody Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 53. Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 54. Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

Figure 55. UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 56. Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 57. South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 58. Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 59. South and Central America: Next-generation Antibody Market, by Key Country – Revenue (2021) (USD Million)

Figure 60. South and Central America Next-generation Antibody Market Revenue and Forecast to 2028 (USD Million)

Figure 61. South and Central America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)

Figure 62. Brazil: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 63. Argentina: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 64. Rest of South & Central America: Next-generation Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 65. Impact of COVID-19 Pandemic in North American Country Markets

Figure 66. Impact of COVID-19 Pandemic in European Country Markets

Figure 67. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 68. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 69. Impact of COVID-19 Pandemic in South and Central American Countries

Figure 70. Growth Strategies in the Next-generation Antibody Market (%)

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Please use your business email for quicker response

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.